Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

doi:10.1097/GME.0b013e318268ca46

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

Menopause (New York, N.Y.) - 1 Mar 2013

Andersen Shaneda Warren, Trentham-Dietz Amy, Figueroa Jonine D, Titus Linda J, Cai Qiuyin, Long Jirong, Hampton John M, Egan Kathleen M, Newcomb Polly A

Abstract excerpt

OBJECTIVE: Genomewide association studies have consistently found variants in fibroblast growth factor receptor 2 (FGFR2) to be associated with breast cancer. Recent reports suggest that postmenopausal hormone therapy (HT) use may modify the association between single nucleotide polymorphisms (SNPs) in FGFR2 and breast cancer risk. We assessed the hypothesis that the association between rs1219648 (FGFR2) SNP and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Replacement Therapy

Share to Estrogens

Share to Odds Ratio

Share to Postmenopause

Share to Progestins

Share to Receptor, Fibroblast Growth Factor, Type 2

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 23435034
DOI: 10.1097/GME.0b013e318268ca46
PMCID: PMC3549049

Genes

FGFR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.PMID 23435034Read ↗

Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.Semantic proximity Read ↗

Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.Semantic proximity Read ↗

Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.Semantic proximity Read ↗

Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.Semantic proximity Read ↗

Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.Semantic proximity Read ↗

Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women.Semantic proximity Read ↗

A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.Semantic proximity Read ↗

Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.Semantic proximity Read ↗

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.Semantic proximity Read ↗

Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis.Semantic proximity Read ↗

Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.